Washington D.C., Jan 2, 2019 / 18:01 pm
Pediatric endocrinologists are warning that despite a lack of medical tests to determine its safety, U.S. doctors are increasingly injecting children who have gender dysphoria with a powerful hormonal suppressant normally used to treat prostate cancer.
"[Parents] need to continue to love their children. They need to continue to affirm their human dignity. Yet they shouldn't have to jettison biological reality to be able to put what they're being told into practice, in terms of disrupting normally timed puberty," Dr. Paul Hruz, an associate professor of pediatrics and endocrinology at Washington University in St. Louis, told The Christian Post.
Leuprorelin, sold under the brand name Lupron, has never been green-lighted by the Food and Drug Administration to treat gender dysphoria, nor have there been any peer-reviewed studies done on the drug's long-term physical and psychological side effects on children, The Christian Post reports.
The Christian Post interviewed several doctors in a recent report who said synthetic hormones could put children on a pathway to permanent sterilization, and many other long-term repercussions which may not be felt for years.